222 related articles for article (PubMed ID: 32383329)
1. MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders.
Frasca A; Spiombi E; Palmieri M; Albizzati E; Valente MM; Bergo A; Leva B; Kilstrup-Nielsen C; Bianchi F; Di Carlo V; Di Cunto F; Landsberger N
EMBO Mol Med; 2020 Jun; 12(6):e10270. PubMed ID: 32383329
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
3. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
5. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
Kaufmann WE; Johnston MV; Blue ME
Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
[TBL] [Abstract][Full Text] [Related]
7. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
[TBL] [Abstract][Full Text] [Related]
8. Rett syndrome: the complex nature of a monogenic disease.
Renieri A; Meloni I; Longo I; Ariani F; Mari F; Pescucci C; Cambi F
J Mol Med (Berl); 2003 Jun; 81(6):346-54. PubMed ID: 12750821
[TBL] [Abstract][Full Text] [Related]
9. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
10. The relationship of Rett syndrome and MECP2 disorders to autism.
Neul JL
Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951
[TBL] [Abstract][Full Text] [Related]
11. Multiplex epigenome editing of
Qian J; Guan X; Xie B; Xu C; Niu J; Tang X; Li CH; Colecraft HM; Jaenisch R; Liu XS
Sci Transl Med; 2023 Jan; 15(679):eadd4666. PubMed ID: 36652535
[TBL] [Abstract][Full Text] [Related]
12. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
Peddada S; Yasui DH; LaSalle JM
Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
[TBL] [Abstract][Full Text] [Related]
14. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
15. Surface- and voxel-based brain morphologic study in Rett and Rett-like syndrome with MECP2 mutation.
Shiohama T; Levman J; Takahashi E
Int J Dev Neurosci; 2019 Apr; 73():83-88. PubMed ID: 30690146
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CpG binding protein 2 (MeCP2) localizes at the centrosome and is required for proper mitotic spindle organization.
Bergo A; Strollo M; Gai M; Barbiero I; Stefanelli G; Sertic S; Cobolli Gigli C; Di Cunto F; Kilstrup-Nielsen C; Landsberger N
J Biol Chem; 2015 Feb; 290(6):3223-37. PubMed ID: 25527496
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive longitudinal study of magnetic resonance imaging identifies novel features of the Mecp2 deficient mouse brain.
Carli S; Chaabane L; De Rocco G; Albizzati E; Sormonta I; Calligaro S; Bonizzi P; Frasca A; Landsberger N
Neurobiol Dis; 2023 May; 180():106083. PubMed ID: 36931532
[TBL] [Abstract][Full Text] [Related]
19. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.
Lyst MJ; Ekiert R; Ebert DH; Merusi C; Nowak J; Selfridge J; Guy J; Kastan NR; Robinson ND; de Lima Alves F; Rappsilber J; Greenberg ME; Bird A
Nat Neurosci; 2013 Jul; 16(7):898-902. PubMed ID: 23770565
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 deficiency is associated with impaired microtubule stability.
Delépine C; Nectoux J; Bahi-Buisson N; Chelly J; Bienvenu T
FEBS Lett; 2013 Jan; 587(2):245-53. PubMed ID: 23238081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
